Clinical trial
Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)
NCT00479726 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00479726 |
|---|---|
| Title | Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS) |
| Official title | Lilly's Emotional and Physical Symptoms of Depression Study |
| Acronym | LEAPS |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depressive Disorder |
| Intervention type | Drug |
| Interventions | duloxetine hydrochloride |
| Enrollment | 8,000 |
| Start date | Aug 1, 2004 |
| Completion | Jan 1, 2005 |
| First posted | May 28, 2007 |
| Last update posted | May 28, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: